Results 131 to 140 of about 5,090 (179)

Ipilimumab/Talimogene Laherparepvec Regimen [PDF]

, 2020
openaire   +1 more source

Multimodal Therapy Approaches for NUT Carcinoma by Dual Combination of Oncolytic Virus Talimogene Laherparepvec with Small Molecule Inhibitors. [PDF]

Viruses
Sotiriadis S, Beil J, Berchtold S, Smirnow I, Schenk A, Lauer UM.   +5 more
europepmc   +1 more source

Intralesional Talimogene Laherparepvec Regimen [PDF]

, 2020
openaire   +1 more source

Resolution of metastatic neck nodes associated with a periauricular cutaneous squamous cell carcinoma after intranodal injection of talimogene laherparepvec. [PDF]

JAAD Case Rep
Che Y, Chong C, Limova M, Morris L, Reddy SA, Chang ALS.   +5 more
europepmc   +1 more source

Intratumoral Talimogene Laherparepvec Therapy in Melanoma [PDF]

Melanoma Management, 2015
openaire   +2 more sources

Metastatic melanoma with diffuse melanosis histologically after stable response to talimogene laherparepvec therapy

JAAD Case Reports, 2018
Jason M. Rizzo, MD, PhD, Leslie A. Fecher, MD, May P. Chan, MD, Alison B. Durham, MD   +3 more
doaj   +1 more source

Talimogene laherparepvec for regionally advanced Merkel cell carcinoma: A report of 2 cases

JAAD Case Reports, 2017
Jonathan T. Blackmon, Ratika Dhawan, MBBS, MPH, Toni M. Viator, RN, Nina L. Terry, MD, JD, Robert M. Conry, MD   +4 more
doaj   +1 more source

Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma. [PDF]

Nat Commun
Joo V, Abdelhamid K, Noto A, Latifyan S, Martina F, Daoudlarian D, De Micheli R, Pruijm M, Peters S, Hullin R, Gaide O, Pantaleo G, Obeid M.   +12 more
europepmc   +1 more source

New drugs: Talimogene laherparepvec [PDF]

Australian Prescriber, 2017
openaire   +1 more source